Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fortress Biotech Employees
Fortress Biotech had 186 employees as of December 31, 2023. The number of employees decreased by 1 or -0.53% compared to the previous year.
Employees
186
Change (1Y)
-1
Growth (1Y)
-0.53%
Revenue / Employee
$438,177
Profits / Employee
-$309,274
Market Cap
47.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inovio Pharmaceuticals | 122 |
AlloVir | 112 |
Omega Therapeutics | 94 |
iCAD, Inc. | 69 |
Kezar Life Sciences | 58 |
vTv Therapeutics | 16 |
Iterum Therapeutics | 14 |
Nutriband | 13 |
FBIO News
- 8 days ago - Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) - GlobeNewsWire
- 5 weeks ago - Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 5 weeks ago - Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewsWire
- 2 months ago - Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 3 months ago - Fortress Biotech to Participate in October 2024 Investor Conferences - GlobeNewsWire